Basic Information:
Name:
Purevax RCPCh
Lyophilisate and solvent for suspension for injection for cats
Composition:
One 1 ml or 0.5 ml dose contains:
Active ingredients:
Lyophilisate:
Attenuated feline rhinotracheitis virus (herpesvirus strain FHV F2) ≥ 104.9 GCID501
Inactivated feline calicivirus antigens (strains FCV 431 and G1) ≥ 2.0 ELISA-E.
Attenuated Chlamydophila felis (strain 905) ≥ 103.0 EID502
Attenuated feline panleukopenia virus (strain PLI IV) ≥ 103.5 GCID501
1 Tissue culture infectious dose 50%
2 Egg infectious dose 50%
Solvent:
Water for injection q.s. 1 ml or 0.5 ml.
Indications:
Active immunization of cats from 8 weeks of age:
- against feline rhinotracheitis (herpesvirus infection) to reduce clinical symptoms,
- against calicivirus infection to reduce clinical symptoms,
- against Chlamydophila felis infection to reduce clinical symptoms,
- against feline panleukopenia to prevent mortality and clinical symptoms.
The onset of immunity against rhinotracheitis virus, calicivirus, Chlamydophila felis, and panleukopenia virus was demonstrated 1 week after primary vaccination.
Duration of immunity:
- Rhinotracheitis virus, calicivirus, and panleukopenia virus: 1 year after primary vaccination and 3 years after the last booster vaccination.
- Chlamydophila felis: 1 year after the last booster vaccination.
Contraindications:
None.
Adverse reactions
Cats:
Common (1 to 10 animals per 100 treated animals):
Transient lethargy, anorexia, and hyperthermia (observed during safety and field studies).
Injection site reactions (mild pain on palpation, itching, or localized swelling)2 (observed during safety and field studies)
Uncommon (1 to 10 animals per 1,000 treated animals):
Hypersensitivity reaction3 (observed in field studies)
Very rare (< 1 animal per 10,000 treated animals, including isolated reports):
Vomiting4, transient hyperthermia, and lethargy, sometimes accompanied by lameness5 (based on post-marketing experience)
1 Usually lasting 1 to 2 days
2 Usually resolve within 1 or at most 2 weeks
3 May require appropriate symptomatic treatment
4 Usually within 24 to 48 hours
5 Observed 1 to 3 weeks after booster vaccination in adult cats
Pharmaceutical company:
Boehringer Ingelheim Vetmedica GmbH